NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -1.97%73.511.0%$1662.26m
AMGNAmgen, Inc. -0.45%218.211.3%$912.64m
REGNRegeneron Pharmaceuticals, Inc. 0.12%512.962.6%$838.70m
BIIBBiogen, Inc. 1.29%321.051.5%$803.32m
VRTXVertex Pharmaceuticals, Inc. -1.22%246.611.9%$654.46m
ILMNIllumina, Inc. 2.36%287.623.5%$500.86m
MRNAModerna, Inc. -1.73%31.860.0%$490.05m
ALXNAlexion Pharmaceuticals, Inc. -2.36%96.232.0%$302.00m
AAgilent Technologies, Inc. 2.14%78.331.6%$228.79m
INCYIncyte Corp. -1.07%86.812.5%$215.18m
EXASEXACT Sciences Corp. 1.04%67.0621.0%$180.99m
SGENSeattle Genetics, Inc. 0.54%120.326.1%$157.23m
BMRNBioMarin Pharmaceutical, Inc. -0.06%79.554.3%$148.36m
IMMUImmunomedics, Inc. 6.57%19.6411.9%$133.04m
NVAXNovavax, Inc. -0.76%17.05114.7%$128.79m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.